DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Possinger K, Kaufmann M, Coleman R. et al.
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Anticancer Drugs 1999; 10: 155-162
We do not assume any responsibility for the contents of the web pages of other providers.